Skip to content
logo-mono-2

We're stepping
up

Read all about our reconsidered and expanded mission to ensure the most vulnerable among us have access to affordable, life-saving medicines.

Read more →

Who we are

  • About Fabtech
  • Investors
    • Disclosure Under Regulation 46
    • Board of Directors, its Committees And Our Team
      • Board Of Directors
      • Board Committees
      • Key Managerial Personnel
      • Senior Managerial Personnel (Our Team)
    • Investors Information
      • Shareholder Information
      • Dividend
      • IEPF Related
      • Other Statutory Disclosures
      • Intimations to Stock Exchange
      • Notice of General Meetings
    • Financials Highlights
      • Financial Results
      • Annual Reports
      • Annual Returns
      • Subsidiaries Financials
      • Group Companies Financials
    • Policies
    • IPO Related Documents
      • Offer Documents
        • Draft Red Herring Prospectus
      • Material Contracts And Documents
        • Material Contract
        • Material Documents
      • Industry Report
    • Corporate Social Responsibility
      • CSR Committee Composition
      • CSR Policy
      • CSR Projects
    • Shareholding Pattern
    • Material Creditors
  • Careers
  • Events
  • Contact Us

Solutions we offer

  • Start-to-Finish
  • Solutions for Air
  • Solutions for Water
  • Solutions for Process

Our references

  • Case Studies
  • Projects
  • Blog
logo-mono-2
  • Who we are
  • Solutions we offer
  • Our references
  • About Fabtech
  • We’re stepping up
  • Careers
  • Events
  • Contact Us
  • INVESTORS
    • Disclosure Under Regulation 46
    • Board of Directors, its Committees And Our Team
      • Board Of Directors
      • Board Committees
      • Key Managerial Personnel
      • Senior Managerial Personnel (Our Team)
    • Investors Information
      • Shareholder Information
      • Dividend
      • IEPF Related
      • Other Statutory Disclosures
      • Intimations to Stock Exchange
      • Notice of General Meetings
    • Financials Highlights
      • Financial Results
      • Annual Reports
      • Annual Returns
      • Subsidiaries Financials
      • Group Companies Financials
    • Policies
    • IPO Related Documents
      • Offer Documents
        • Draft Red Herring Prospectus
      • Material Contracts And Documents
        • Material Contract
        • Material Documents
      • Industry Report
    • Corporate Social Responsibility
      • CSR Committee Composition
      • CSR Policy
      • CSR Projects
    • Shareholding Pattern
    • Material Creditors
  • Start-To-Finish
  • Solutions For Air
  • Solutions For Water
  • Solutions For Process
  • Case Studies
  • Projects
  • Blog

Pharma companies in West Africa partner with us to build indigenous drug manufacturing capability, so children like Emmanuela have better access to affordable life-saving medicines.
Together, we're saving lives.
Read the Fidson case study
We're building all the BSL-3 facilities the developing world needs so the world is better prepared for whatever comes next. READ THE GoUP CASE STUDY Bio-pharma companies in Latin America partner with us to build indigenous drug manufacturing capability so children like Gabriela have better access to affordable life-saving medicines. Together, we're stepping up to save lives. Read the Mechnikov case study Bio-pharma companies in North Africa partner with us to build indigenous drug manufacturing capability so children like Aliyeh grow up in a more equitable world.
Together, we're stepping up to save lives.
Read the North Africa case study
Pharma companies in KSA partner with us to build indigenous drug manufacturing capability so children like Hamza have better access to life-saving medicines READ THE SUDAIR CASE STUDY Global bio-pharma companies partner with us to expand drug manufacturing capability in different parts of the world so children like Valentina have better access to essential vaccines.
Together, we're stepping up to save lives.
READ THE UMICORE CASE STUDY
Bio-pharma companies in Sri Lanka partner with us to establish R&D facilities so that children like Sarath can have access to high quality life-saving drugs. Read the case study

Read the Fidson case study READ THE GoUP CASE STUDY Read the Mechnikov case study Read the NORTH AFRICA case study Read the Sudair case study READ THE UMICORE CASE STUDY Read the case study
Scroll To Top